XRAYNasdaqDental Equipment & SuppliesFiscal year ends December 31
DENTSPLY SIRONA Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$8.42−0.15 (-1.75%)
Close on Oct 19, 2026
- Market cap
- $1.69B
- P/E (TTM)
- –
- Dividend yield
- 7.60%
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
50.0%+0.4 pts over 5 years
Operating margin
-11.5%−11.4 pts over 5 years
Net margin
-16.3%−14.1 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -3.0% | -2.1% | +2.0% | +3.2% | |
| Gross profit | -6.0% | -4.7% | +2.1% | +1.9% | |
| Free cash flow | -63.0% | -34.4% | -28.6% | -13.1% | |
| Dividend per share | 0.0% | +8.6% | +9.9% | +8.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 8.2% | -1.5% | -36.5% | |
| Return on assets | 5.4% | -0.8% | -10.7% | |
| Current ratio | 2.27 | 1.31 | 1.51 | |
| Debt to equity | 0.19 | 0.46 | 1.74 | |
| Net debt to EBITDA | 1.58× | 5.56× | -28.60× | |
| Interest coverage | 12.7× | -0.1× | -4.8× | |
| Inventory turnover | 4.1× | 3.2× | 3.1× | |
| Capex to revenue | 3.3% | 2.6% | 3.6% | |
| Diluted shares | 222M | 219M | 199M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Dentsply Sirona generated $2.25B from operations and spent $2.22B on capital expenditure, dividends and share buybacks. 34% of that went back into the business.
Generated
$2.25B
Used
$2.22B
Capital expenditure$751.00M34%Dividends$566.00M26%Share buybacks$900.00M41%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-16.3%
×Asset turnover0.66×
×Equity multiplier3.41×
=Return on equity, FY2025-36.5%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -16.3% | 0.66× | 3.41× | -36.5% |
| FY2024 | -24.0% | 0.58× | 2.51× | -34.8% |
| FY2023 | -3.3% | 0.53× | 2.11× | -3.7% |
| FY2022 | -24.2% | 0.46× | 1.92× | -21.6% |
| FY2021 | 9.7% | 0.46× | 1.87× | 8.3% |
| FY2020 | -2.2% | 0.37× | 1.79× | -1.5% |
| FY2019 | 6.4% | 0.47× | 1.69× | 5.0% |
| FY2018 | -25.4% | 0.42× | 1.62× | -17.2% |
| FY2017 | -38.8% | 0.36× | 1.49× | -21.0% |
| FY2016 | 11.5% | 0.47× | 1.53× | 8.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$598.00M
- Cash generatingOperating cash flow above zero$235.00M
- Return on assets improvedROA up on the prior year-12.3% → -10.4%
- Earnings backed by cashOperating cash flow above net income$235.00M vs -$598.00M
- Less leverageLong-term debt to assets fell27.6% → 37.1%
- Better liquidityCurrent ratio rose1.10 → 1.51
- No dilutionShare count did not rise203M → 199M
- Gross margin improvedGross margin up on the prior year51.62% → 50.00%
- More efficientAsset turnover rose0.51 → 0.64